What is ADMA Biologics's revenue?

ADMA Biologics (ADMA) generated $509.9M in revenue over the trailing twelve months, up 11.0% year over year.

Is ADMA Biologics profitable?

ADMA Biologics reported $165.4M in net income over the trailing twelve months, a 32.4% net margin.

What are ADMA Biologics's profit margins?

Gross margin is 61.3% and operating margin is 42.1%, with a 32.4% net margin.

What is ADMA Biologics's earnings per share?

ADMA Biologics's diluted EPS over the trailing twelve months is $0.68.

Where does ADMA Biologics's income statement data come from?

Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ADMA Biologics ADMA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$114.49M-0.3%	$139.16M+18.4%	$134.22M+12.0%	$121.98M+13.8%	$114.8M+40.2%
Total cost of revenue	$33.74M-37.2%	$50.35M-7.1%	$58.6M-2.6%	$54.76M+10.1%	$53.71M+25.6%
Gross profit	$80.75M+32.2%	$88.82M+40.2%	$75.63M+26.8%	$67.23M+17.0%	$61.1M+56.2%
Gross margin	70.5%+17.3pp	63.8%+9.9pp	56.3%+6.6pp	55.1%+1.5pp	53.2%+5.5pp
Research and development	$2.6M+214%	$1.38M+252%	$1.53M+271%	$1.03M+84.1%	$826K+83.6%
Selling, general and administrative	$26.74M+11.1%	$23.51M+0.8%	$21.78M+17.3%	$22.21M+33.8%	$24.08M+54.0%
Selling and marketing	——	$775K+14.8%	$775K+14.8%	$775K+14.8%	$775K+14.8%
Total operating expenses	$22.48M-14.3%	$26.07M+4.2%	$24.61M+22.9%	$24.43M+33.8%	$26.22M+51.7%
Operating income	$58.27M+67.1%	$62.75M+63.7%	$51.01M+28.7%	$42.8M+9.2%	$34.88M+59.9%
Operating margin	50.9%+20.5pp	45.1%+12.5pp	38%+4.9pp	35.1%-1.5pp	30.4%+3.7pp
Interest expense	$2.1M+6.3%	$1.63M-43.5%	$1.68M-52.1%	$1.83M-51.5%	$1.98M-47.6%
Other income (expense), net	-$1.15M+19.8%	-$1.16M+68.0%	-$3.5M-21.0%	-$2.7M+19.4%	-$1.43M+58.2%
Income before income taxes	$57.13M+70.8%	$61.6M+77.4%	$47.52M+29.3%	$40.1M+11.8%	$33.45M+81.8%
Income tax expense	$11.8M+80.2%	$12.22M+116%	$11.09M+1,220%	$5.88M+55.1%	$6.55M+1,000%
Net income	$45.33M+68.5%	$49.38M-55.9%	$36.43M+1.4%	$34.22M+6.7%	$26.9M+51.1%
Net margin	39.6%+16.2pp	35.5%-59.7pp	27.1%-2.8pp	28.1%-1.9pp	23.4%+1.7pp
Diluted earnings per share	$0.19+72.7%	$0.20-56.5%	$0.150.0%	$0.14+7.7%	$0.11+37.5%
EBITDA	$60.07M+63.3%	$64.75M+60.6%	$53.01M+27.6%	$44.8M+9.0%	$36.78M+55.1%
EBITDA margin	52.5%+20.4pp	46.5%+12.2pp	39.5%+4.8pp	36.7%-1.6pp	32%+3.1pp
EBIT	$58.27M+67.1%	$62.75M+63.7%	$51.01M+28.7%	$42.8M+9.2%	$34.88M+59.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ADMA Biologics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's revenue?: ADMA Biologics (ADMA) generated $509.9M in revenue over the trailing twelve months, up 11.0% year over year.
Is ADMA Biologics profitable?: ADMA Biologics reported $165.4M in net income over the trailing twelve months, a 32.4% net margin.
What are ADMA Biologics's profit margins?: Gross margin is 61.3% and operating margin is 42.1%, with a 32.4% net margin.
What is ADMA Biologics's earnings per share?: ADMA Biologics's diluted EPS over the trailing twelve months is $0.68.
Where does ADMA Biologics's income statement data come from?: Every line is extracted from ADMA Biologics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.